News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
News By Date


Thursday, July 31, 2014

Top Breaking News
Menlo Park's Avalanche Biotechnologies (AAVL) Rolls Onto Nasdaq, Raises $102 Million For Its IPO
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Bag BioMarin Pharmaceutical Inc. (BMRN)'s Special FDA Priority Review Voucher For $67.5 Million
Novartis AG (NVS) Apologizes For Not Disclosing Side-Effects Of Leukemia Drugs Sooner
AstraZeneca PLC (AZN) Steps Up Push Into Cancer Immunotherapy, Falls Behind Rivals Such As Bristol-Myers Squibb Company (BMY), Merck & Co., Inc. (MRK), And Roche (RHHBY)
Flailing Dendreon Corporation (DNDN) Brings In Ex-Johnson & Johnson (JNJ) Exec For Top CEO Post
Meda AB (MEDA-A.ST) Bags Rottapharm $3.08 Billion To Create A European Pharma Powerhouse
FDA Panel Reviews Safety Of Baxter International, Inc. (BAX)'s Experimental Drug For Immune System Disorders
FDA Approves Boehringer Ingelheim Pharmaceuticals, Inc.'s Once-A-Day Inhaler Drug Striverdi For Chronic Lung Disease Patients
Cambridge-Based Gen9 Gets $25 Million In Equity Funding For DNA Synthesis
Catalent Pharma Solutions (CTLT) Prices IPO At Midpoint Range, Raises $871 Million
Epilepsy Biotech Marinus Pharmaceuticals (MRNS) Prices IPO At $10/Share
SoCal Biopharma Cold Genesys, Inc. Locks In $13.57 Million Series A
Sanofi (France) (SAN.PA) Second Quarter Profit Jumps 73 Percent; Earnings Outlook Lifted
Israeli Biotech Macrocure Sets Terms for $75 Million IPO
50 Jobs Promised As Stem Cell Company Precious Cells BioBank Gets Bigger
FDA Concern Over Drug Production Process At India's Cadila
CytoDyn Announces Positive Interim Results From Its Treatment Substitution Study in Patients With HIV
Regeneron Pharmaceuticals, Inc. (REGN) Release: EYLEA® (aflibercept) Injection Receives FDA Approval For The Treatment Of Diabetic Macular Edema (DME)

Featured Stories
Puma Biotechnology (PBYI)'s Overnight Billionaire On One Of His Keys To Success
Insiders Reveal Valeant Pharmaceuticals International (VRX)'s Cost Cutting May Have Gone Too Far
Gilead Sciences, Inc. (GILD) Popular Amongst Latest 13F Filers
Psychologists Discover A Surprising Thing Happens To Kids Who Read Harry Potter, University of Modena Reveals
Common Pesticide Linked To Slow Metabolism, Obesity, And Diabetes, University of California, Davis (UCD) Study
Tree Nuts May Fight Metabolic Disease, Diabetes, St. Michael's Hospital Study
Soy May Help Women's Hearts If They Start Early, Wake Forest University School of Medicine Study
8 Fascinating Facts About Tears You Need To Know, University of California, Berkeley (CAL) Reveals
Light Shed On How Depression Is Related To Dementia, Rush University Medical Center Study

More News
New Data On Chimerix, Inc. (CMRX)'s brincidofovir Supports Safety And Antiviral Activity Against Multiple Life-Threatening DNA Viruses In Organ Transplant Recipients
Kala Pharmaceuticals Initiates Phase 2 Clinical Trial To Evaluate LE-MPP (KPI-121) In Patients With Retinal Vein Occlusion And Diabetic Macular Edema
Expanded Data On Disability And Cognitive Improvements In Phase 2 Study Of Synthetic Biologics, Inc. (SYN)' Trimesta™ In Multiple Sclerosis To Be Presented At 2014 Joint ACTRIMS-ECTRIMS Meeting
NOXXON Pharma AG Initiates Phase IIa Study Of Anti-Hepcidin Spiegelmer® Lexaptepid Pegol (NOX-H94) In Dialysis Patients With EPO-hyporesponsive Anemia
AFFiRiS AG Presents Phase I Data On A First-Of-Its-Kind Treatment With Support From The Michael J. Fox Foundation
Cara Therapeutics, Inc. (CARA) Initiates Human Abuse Liability Trial Of CR845
AFFiRiS AG Release: First Clinical Data Of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development
BioTime (BTX) Subsidiary OncoCyte Corporation Expands Clinical Development Of Bladder Cancer Diagnostic By Initiating A Large Multi-Site Clinical Trial
Biotech Support Group Release: Review Article Cites HemoVoid™ & HemogloBind™ For Comprehensive RBC Proteome Analysis
ESTEVE Announces The Start Of A Natural History Study In Patients With Sanfilippo Syndrome Type A (MPSIIIA)
The Rendon Center for Dermatology and Aesthetic Medicine Release: Indoor And Outdoor Sun Tanning Or Sun Burns Directly Linked To Deadly Melanoma Skin Cancer
Pfizer Inc. (PFE)’s Stake In Cellectis (ALCLS)’ Capital Is Welcomed By Its Shareholders
Cortice Biosciences Announces Acquisition Of Exclusive Rights To A Novel Neurological Disease Therapeutic And Development Platform
Invitae And Nanopharmacia Announce Partnership To Make Reliable, Fast And Affordable Hereditary Cancer Genetic Testing Broadly Available In Mexico
Anika Therapeutics (ANIK) Announces U.S. Commercialization Partnership For Hyalomatrix® With Wound Care Leader Medline Industries, Inc.
Rogne Bioscience, Inc. Release: Oxford Licenses Anti-Inflammatory Peptides To San Francisco Bay Area Start-Up
Columbia Laboratories, Inc. (CBRX)'s Subsidiary, Molecular Profiles, Strikes Alliance With XenoGesis Ltd.
AIBioTech Teams With Leidos For Air Force Contract
ChromaDex, Inc. Signs Material Transfer Agreement With Prominent Australian Research Institute For NIAGEN™ Research
Catylix, Inc. And Aspira Scientific Announce Joint Venture To Commercialize New Fluorination Technologies
Sirona Biochem Announces Successful Synthesis Of Anti-Inflammatory Compound For Bloom Burton & Co. Joint Venture
RBCC 3D Bioprinting Partner Awarded Prestigious Grant
Touro University California Garners Grant From Long Foundation
Mystic Pharmaceuticals Receives Notice Of Allowance For Novel Powder Drug Delivery Technology
PuraMed BioScience Rebrands Its Natural Migraine Relief Medication, Lipigesic M
Transgenomic, Inc. (TBIO) Announces Issuance Of New European Patent Covering COLD-PCR Technologies
CDEX Inc. (CDEX) Granted Notice Of Allowance For U.S. Patent Application Covering Identification And Determination Of Chemical Substances Using Enhanced Photoemission Spectroscopy
Lazarus Effect Closes $5 Million Financing
VBL Therapeutics Announces Pricing Of Initial Public Offering
Innocoll, Inc. (INNL) Announces Closing Of Initial Public Offering
BioBlast Pharma (ORPN) Prices Initial Public Offering Of $35,200,000 Of Ordinary Shares
Number Of Shares And Votes In Orexo AB (ORXOF)
China Cord Blood Corporation Files Its Annual Report On Form 20-F
CytoDyn Announces Investment Community Call To Discuss Interim Results From Its Treatment Substitution Study In Patients With HIV
Cannabis Science Inc. Initiates Scientific Cultivation Programs To Test Multiple Strains Of Cannabis To Obtain Extract Formulations For Clinical Drug Development Targeting Multiple Critical Ailments Starting With Cancer And Neurological Disorders
Israel's Ministry Of Health Approves Pluristem Therapeutics (PSTI)'s Commercial-Scale 3D Cell Manufacturing Process Used At Its New Haifa Facility
Zealand Pharma  (ZEAL.CO) Reports Increased Lyxumia® Royalty Revenue For H1 2014 And Informs Of Status Update As Provided By Sanofi
Weill Cornell Medical College Selects OpenTempo Workforce Optimization Solution
Unilife Corporation (UNIS) Accelerates Investment To Meet Increasing Demand From New And Existing Customers
Walgreens Named Exclusive Specialty Pharmacy Provider For Sigma-Tau Pharmaceuticals’s, Prescription Drugs: Adagen®, Cystaran Adagen® and Matulane Adagen®
CCRM Uses ambr15 For Pluripotent Stem Cell Expansion And Differentiation Research
Senomyx, Inc. (SNMX) Announces Corporate Update And Second Quarter 2014 Financial Results
Intellect Neurosciences, Inc. Issues Letter To Shareholders
All Proposals Approved At Teva Pharmaceutical Industries Limited (TEVA)'s Annual Meeting Of Shareholders
Catalent, Inc. Announces Pricing of Its Initial Public Offering
Matinas BioPharma Launches Digital Corporate Communication Channels
Ocular Therapeutix, Inc. (OCUL) Announces Closing Of Initial Public Offering
Ocular Therapeutix, Inc. (OCUL) To Ring The NASDAQ Stock Market Closing Bell
Gen9 Launches Rationally Designed DNA Variant Libraries
A*STAR And University of Warwick Launch First Engineering Doctorate Programme In Singapore
Successful FDA Inspection At Hovione's API Manufacturing Plant In Cork, Ireland
genae Opens Offices In London
Marken (Formerly known as Marken Time Critical) Expands Miami Regional Logistics Center
iMedicor Launches Proprietary iCoreMD, Cloud-Based, Customizable Electronic Health Records Platform
Dectris Ltd. Introduces Three New Performance Classes Of Hybrid Photon Counting X-Ray Detectors
Anika Therapeutics (ANIK) Reports Second-Quarter 2014 Financial Results
Alkermes plc (ALKS) Reports Second Quarter 2014 Financial Results
BioLife Solutions, Inc. (BLFS.OB) To Report Financial Results For Second Quarter 2014 And Provide Business Update On August 7, 2014
Becton, Dickinson and Company (BDX) Announces Results For 2014 Third Fiscal Quarter
Curis, Inc. (CRIS) To Release Second Quarter 2014 Financial Results And Hold Conference Call On August 7, 2014
Celsion Corporation (CLSN) To Hold Second Quarter 2014 Financial Results
CryoPort, Inc. Reports 92% Revenue Growth For First Quarter Of Fiscal 2015
Cleveland Biolabs Inc. (CBLI) To Report Second Quarter 2014 Financial Results And Provide Operational Update On August 7
Corcept Therapeutics Inc. (CORT) To Announce Second Quarter Financial Results And Host Conference Call
Celator Pharmaceuticals, Inc. To Report Second Quarter 2014 Financial Results On August 7, 2014
Columbia Laboratories, Inc. (CBRX) Reports Second Quarter 2014 Financial Results
Durata Therapeutics, Inc.  (DRTX) To Report Second Quarter 2014 Financial Results On August 7, 2014
DURECT Corporation (DRRX) Invites You To Join Its Second Quarter 2014 Earnings Conference Call
Endo International plc (ENDP) Appoints Shane M. Cooke To Board Of Directors
Endo Pharmaceuticals (ENDP) Reports Second Quarter Financial Results
Flexion Therapeutics (FLXN) To Report Second Quarter 2014 Financial Results On August 7, 2014
Illumina, Inc. (ILMN) Appoints Jeff Huber To Its Board Of Directors
Incyte Corporation (INCY) Reports 2014 Second-Quarter Financial Results And Updates Shareholders On Key Clinical Programs
McKesson Corporation Reports Fiscal 2015 First-Quarter Results
Minerva Neurosciences, Inc. (NERV) To Host Second Quarter 2014 Financial Results Webcast And Conference Call
Momenta Pharmaceuticals, Inc. (MNTA) Reports Second Quarter 2014 Financial Results
MediWound (MDWD) Reports Second Quarter 2014 Financial Results
Nuvo Research Inc. (NRI.TO) Announces 2014 Second Quarter Results
NovaBay Pharmaceuticals, Inc. (NBY) Reports Second Quarter 2014 Financial Results And A Clinical/Business Update
NephroGenex (NRX) Announces Date Of Conference Call To Discuss Second Quarter 2014 Financial Results
Orexigen Therapeutics, Inc. (OREX) To Host Second Quarter 2014 Financial Results Conference Call And Webcast
Perrigo Company (PRGO) To Release Fourth Quarter And Fiscal Year 2014 Results On August 14, 2014
Pharming Group (PHGUF.PK) Reports On Financial Results First Half Year 2014
Quintiles Reports 2nd Quarter 2014 Results
Regulus Therapeutics, Inc. Announces Timing For Second Quarter 2014 Financial Results Webcast And Conference Call
Synageva BioPharma (GEVA) Reports Second Quarter 2014 Financial Results
Sanofi (France) (SAN.PA) H1 2014 Results - Interview With Chris Viehbacher
SIGA Technologies, Inc. (SIGA) Reports Financial Results For The Second Quarter 2014
Sarepta Therapeutics (SRPT) To Announce Second Quarter 2014 Financial Results And Corporate Update On August 7, 2014
Theravance, Inc. (THRX) To Report Second Quarter 2014 Financial Results On August 6, 2014
Teva Pharmaceutical Industries Limited (TEVA) Reports Second Quarter 2014 Results
Vical Incorporated (VICL) Reports Second Quarter 2014 Financial Results And Progress In Key Development Programs
Valeant Pharmaceuticals International (VRX) Reports Second Quarter 2014 Financial Results
Intra-Cellular Therapies, Inc. Announces The Appointment Of Michael Halstead As Senior Vice President And General Counsel
TB Alliance Names Elana Robertson Senior Vice President, Market Access
TB Alliance Appoints Willo Brock Senior Vice President, External Affairs
Astellas Hires Industry Veteran Moyra Knight As Head Of Corporate And Employee Communications
Thomas C Wright, MD, World Recognized Women’s Health Sciences Authority, Joins Enzo Biochem (ENZ)’s Clinical Division
Envisia Therapeutics Announces Appointments To Board of Directors
Association of Clinical Research Organizations (ACRO) Strongly Endorses COMPETE Act
The Galien Foundation Announces 2014 Prix Galien USA Nominees For "Best Biotechnology Product," "Best Pharmaceutical Agent," And "Best Medical Technology"
SelfEcho Release: New Survey Signals Promise For Mobile Technology To Advance Mental Healthcare Treatment
Chicago Bears Join The American Academy of Dermatology In Fight Against Skin Cancer
JDRF Commends Senators Collins And Shaheen For Introducing Legislation To Ensure Seniors With Diabetes Have Access To Continuous Glucose Monitors
ViSalus Honored With Kaltura Innovation Award And Four Telly Awards
ThromboGenics NV (TBGNF)' JETREA Nominated For 2014 Prix Galien USA
Agilent Technologies, Inc. (Santa Clara, California) (A) To Host Seminars At International Dioxin Symposium In Madrid
Probiodrug AG Presents Pre-clinical And Clinical Findings Of PQ912, A QC-Inhibitor For Alzheimer's Disease
IMRIS CEO Jay D. Miller To Present At InvestMNt 2014 Conference
Institute For Supply Management, Michigan State University To Recognize Companies With Excellent Supply Management Practices
Latista To Exhibit At 2014 ASHE Annual Conference
Momenta Pharmaceuticals, Inc. (MNTA) To Webcast Presentation At The Canaccord Genuity Growth Conference
Enzymotec To Participate In The Canaccord Genuity 34th Annual Growth Conference
Sarepta Therapeutics (SRPT) To Present Company Overview At Canaccord Annual Growth Conference